levofloxacin has been researched along with Lung Neoplasms in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bulcun, E; Çimen, D; Ekici, A; Ekici, M; Güngör, Ö | 1 |
Ge, T; Jiang, J; Sheng, S; Song, M; Wang, G; Wu, H; Wu, S; Zhou, Y | 1 |
Deuss, B; Dickgreber, N; Nagel, S; Pabst, S; Roscher, K; Salm, T; Schuette, W; Schumann, C; von Weikersthal, LF | 1 |
De Simone, C; Famularo, G | 1 |
Amado, J; Carvalho, A; Ferreira, Dde F; Neves, S; Nogueira, R; Taveira, N | 1 |
1 trial(s) available for levofloxacin and Lung Neoplasms
Article | Year |
---|---|
Randomized phase III trial of docetaxel plus carboplatin with or without levofloxacin prophylaxis in elderly patients with advanced non-small cell lung cancer: the APRONTA trial.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Carboplatin; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Docetaxel; Double-Blind Method; Dyspnea; Female; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Leukopenia; Levofloxacin; Lung Neoplasms; Male; Middle Aged; Neutropenia; Ofloxacin; Pain; Taxoids | 2011 |
4 other study(ies) available for levofloxacin and Lung Neoplasms
Article | Year |
---|---|
Case of round pneumonia: pulmonary infarct and a rare situation that is similar with the lung cancer.
Topics: Diagnosis, Differential; Fluoroquinolones; Humans; Levofloxacin; Lung Neoplasms; Male; Middle Aged; Moxifloxacin; Pneumonia; Pulmonary Infarction; Radiography, Thoracic; Treatment Outcome; Young Adult | 2015 |
Antibiotic drug levofloxacin inhibits proliferation and induces apoptosis of lung cancer cells through inducing mitochondrial dysfunction and oxidative damage.
Topics: Aldehydes; Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Proliferation; DNA Damage; Dose-Response Relationship, Drug; Electron Transport Complex I; Electron Transport Complex III; Humans; Levofloxacin; Lung Neoplasms; Mice, SCID; Mitochondria; Oxidative Stress; Reactive Oxygen Species; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |
Nephrotoxicity and purpura associated with levofloxacin.
Topics: Acute Kidney Injury; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Diuretics; Drug Eruptions; Furosemide; Humans; Kidney Function Tests; Levofloxacin; Liver Function Tests; Lung Neoplasms; Male; Myeloproliferative Disorders; Ofloxacin; Prednisone; Purpura | 2002 |
Treatment of pulmonary actinomycosis with levofloxacin.
Topics: Actinomycosis; Anti-Bacterial Agents; Diagnosis, Differential; Female; Humans; Levofloxacin; Lung Diseases; Lung Neoplasms; Middle Aged; Ofloxacin; Tomography, X-Ray Computed | 2008 |